Biohealthmatics.com Biomedical Informatics at OHSU
advertisement
Biohealthmatics Centers
Home
Jobs Search
Career Center
Networking Center
Company Profiles
Knowledge Center
Industry News
Web Directory
Industry Books
Featured Articles

Biohealthmatics.com....linking professionals
advertisement

Join Us

Link To Us


Healthcare IT and Biotechnology News Release
Date of Publication: Monday, July 28, 2008

VisualMED Restructuring to Focus on New Markets

Company Increases Commitment to Oncology, Internet and Clinics
VisualMED Clinical Solutions Corp. (The "Company") (OTCBB: VMCS) (FRANKFURT: VA6) announces that it has completed a comprehensive corporate and operations restructuring in order to focus on its more promising markets of oncology, Internet and private clinics.

"Much of this will involve licensing the technology to resellers such as VisualMED Distribution Inc., Medical.MD and Integrated Cancer Care Corp. VisualMED is to become a provider of technology, implementation support, integration and maintenance services to its licensees and distributors in exchange for fees and a steady royalty stream," notes VisualMED Chairman Gerard Dab. "We will continue to be a developer of unique technology while seeking sales and marketing partnerships. This restructuring allows the company to diversify sources of revenues and helps to keep expenses in line with revenues."

The new business focus is proving promising. Our reception at the American Society of Clinical Oncology (ASCO) 2008 annual meeting in June garnered much attention and sales interest for our oncology technology, particularly at the specialized EHR lab.

With the deployment of our VisualONCOLOGY module at the McGill University affiliated Segal Cancer Center and the coming implementation of at Montreal's St. Mary's Hospital, our oncology platform is rapidly finding a niche in the market for improving cancer care.

We are pursuing our partnership with Plexo Inc. developing a comprehensive clinical management system for this leader in private executive health.

A significant part of this new orientation has been a major overhaul of our executive team that has seen Dr. Arthur Gelston, CFO Mr. Larry Kurlender and VP Finance Ms. Jayne H. Kirby leave the company to pursue other opportunities.

"We will continue to grow our business through new partnerships," concludes Mr. Gerard Dab. "We now focus on markets that are willing and ready to adopt our technology."



Other News Items Published on the Monday, July 28, 2008

 

 

 

   
Copyright © 2009 Biohealthmatics.com. All Rights Reserved. Contact Us - About Us - Privacy Policy - Terms & Conditions - Resources
Can't find what you are looking for? View our Site Map

Last Updated: 24 November 2007.